Location History:
- Oslo, NO (2013)
- Blommenholm, NO (2023)
Company Filing History:
2 out of 31 
2 out of 35 
1 out of 16 Years Active: 2013-2025
Title: **Kjersti Flatmark: Pioneering Cancer Treatment Innovations**
Introduction
Kjersti Flatmark is an esteemed inventor based in Blommenholm, Norway. With a significant contribution to the field of cancer treatment, she holds one patent that showcases her innovative spirit and expertise in medical science.
Latest Patents
Her notable patent, which focuses on the combination of PACA and cabazitaxel for anti-cancer treatment, describes an active ingredient encapsulated into poly (alkyl cyanoacrylate) nanoparticles. This innovative approach is employed in anti-cancer treatments via intraperitoneal administration, marking a significant advancement in targeted cancer therapies.
Career Highlights
Throughout her career, Kjersti Flatmark has worked with prestigious organizations, including SINTEF Technology Transfer and Oslo University Hospital. Her work in these institutions has provided her with a platform to develop and refine her innovative ideas, particularly in the realm of cancer therapies.
Collaborations
Kjersti has collaborated with several talented individuals in her field, including her colleagues Yrr Morch and Einar Sulheim. Their joint efforts have contributed to the successful development of her research and inventions, underscoring the importance of teamwork in scientific advancement.
Conclusion
Kjersti Flatmark exemplifies the role of inventors in pushing the boundaries of medical science. Her innovative patent and collaborations with esteemed professionals highlight her commitment to improving cancer treatments, making a significant impact in the medical community.